HK1209726A1 - Protein kinase inhibitors - Google Patents
Protein kinase inhibitorsInfo
- Publication number
- HK1209726A1 HK1209726A1 HK15110338.3A HK15110338A HK1209726A1 HK 1209726 A1 HK1209726 A1 HK 1209726A1 HK 15110338 A HK15110338 A HK 15110338A HK 1209726 A1 HK1209726 A1 HK 1209726A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein kinase
- kinase inhibitors
- inhibitors
- protein
- kinase
- Prior art date
Links
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2782774A CA2782774A1 (en) | 2012-07-06 | 2012-07-06 | Protein kinase inhibitors |
| PCT/CA2013/000612 WO2014005217A1 (en) | 2012-07-06 | 2013-07-03 | Protein kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1209726A1 true HK1209726A1 (en) | 2016-04-08 |
Family
ID=49881186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15110338.3A HK1209726A1 (en) | 2012-07-06 | 2015-10-21 | Protein kinase inhibitors |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9447102B2 (xx) |
| EP (1) | EP2870158B1 (xx) |
| JP (1) | JP6190881B2 (xx) |
| KR (2) | KR20180107328A (xx) |
| CN (1) | CN104718207B (xx) |
| BR (1) | BR112014033056A2 (xx) |
| CA (2) | CA2782774A1 (xx) |
| ES (1) | ES2631228T3 (xx) |
| HK (1) | HK1209726A1 (xx) |
| IN (1) | IN2014MN02554A (xx) |
| RU (1) | RU2679122C2 (xx) |
| WO (1) | WO2014005217A1 (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2782774A1 (en) * | 2012-07-06 | 2014-01-06 | Pharmascience Inc. | Protein kinase inhibitors |
| CA2833701A1 (en) * | 2013-11-19 | 2015-05-19 | Pharmascience Inc. | Protein kinase inhibitors |
| CA2833867A1 (en) | 2013-11-21 | 2015-05-21 | Pharmascience Inc. | Protein kinase inhibitors |
| CA2834528A1 (en) * | 2013-11-26 | 2015-05-26 | Pharmascience Inc. | Protein kinase inhibitors |
| CN103787839B (zh) * | 2014-01-21 | 2015-12-02 | 苏州昊帆生物科技有限公司 | 合成2,3,4,5,6-五氟苯酚的方法 |
| EP3337805A4 (en) * | 2015-05-27 | 2019-04-03 | Pharmascience Inc. | INHIBITORS OF THE ENZYME FAMILY KINASES TEC |
| US10611766B2 (en) * | 2015-09-16 | 2020-04-07 | Loxo Oncology Inc. | Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer |
| WO2017134685A2 (en) * | 2016-02-02 | 2017-08-10 | Sun Pharma Advanced Research Company Limited | Novel hydrazino compounds as btk inhibitors |
| WO2018033091A1 (zh) * | 2016-08-17 | 2018-02-22 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制酪氨酸激酶活性的稠合双环类化合物 |
| CN114364798A (zh) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | 用于治疗癌症的Dbait分子与激酶抑制剂的组合 |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3736728A1 (de) * | 1987-10-29 | 1989-05-11 | Siemens Ag | Druckertinte |
| EP0589335B1 (de) * | 1992-09-24 | 2003-06-18 | Hoechst Aktiengesellschaft | N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel |
| TR200201506T2 (tr) | 1999-09-17 | 2002-10-21 | Abbott Gmbh & Co. Kg | Terapötik maddeler olarak kinaz inhibitörleri |
| DE10031584A1 (de) * | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine |
| US20030199525A1 (en) * | 2002-03-21 | 2003-10-23 | Hirst Gavin C. | Kinase inhibitors |
| JP5347202B2 (ja) * | 2007-03-28 | 2013-11-20 | ファーマサイクリックス，インク． | ブルトンチロシンキナーゼインヒビター |
| CA2782774A1 (en) * | 2012-07-06 | 2014-01-06 | Pharmascience Inc. | Protein kinase inhibitors |
| RS58023B2 (sr) * | 2012-11-01 | 2021-12-31 | Infinity Pharmaceuticals Inc | Lečenje kancera korišćenjem modulatora izoformi pi3 kinaza |
-
2012
- 2012-07-06 CA CA2782774A patent/CA2782774A1/en not_active Abandoned
-
2013
- 2013-07-03 CN CN201380036106.0A patent/CN104718207B/zh not_active Expired - Fee Related
- 2013-07-03 KR KR1020187027447A patent/KR20180107328A/ko active IP Right Grant
- 2013-07-03 US US14/412,982 patent/US9447102B2/en not_active Expired - Fee Related
- 2013-07-03 WO PCT/CA2013/000612 patent/WO2014005217A1/en active Application Filing
- 2013-07-03 RU RU2014151421A patent/RU2679122C2/ru not_active IP Right Cessation
- 2013-07-03 KR KR1020157003221A patent/KR101903123B1/ko active IP Right Grant
- 2013-07-03 CA CA2878332A patent/CA2878332C/en not_active Expired - Fee Related
- 2013-07-03 BR BR112014033056A patent/BR112014033056A2/pt not_active Application Discontinuation
- 2013-07-03 EP EP13813932.4A patent/EP2870158B1/en not_active Not-in-force
- 2013-07-03 JP JP2015518741A patent/JP6190881B2/ja not_active Expired - Fee Related
- 2013-07-03 IN IN2554MUN2014 patent/IN2014MN02554A/en unknown
- 2013-07-03 ES ES13813932.4T patent/ES2631228T3/es active Active
-
2015
- 2015-10-21 HK HK15110338.3A patent/HK1209726A1/xx unknown
-
2016
- 2016-09-12 US US15/262,193 patent/US9795608B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2631228T3 (es) | 2017-08-29 |
| EP2870158A1 (en) | 2015-05-13 |
| CA2782774A1 (en) | 2014-01-06 |
| EP2870158A4 (en) | 2015-12-09 |
| EP2870158B1 (en) | 2017-05-31 |
| US9795608B2 (en) | 2017-10-24 |
| RU2679122C2 (ru) | 2019-02-06 |
| KR101903123B1 (ko) | 2018-10-01 |
| US9447102B2 (en) | 2016-09-20 |
| KR20180107328A (ko) | 2018-10-01 |
| CN104718207B (zh) | 2017-08-15 |
| RU2014151421A (ru) | 2016-08-27 |
| CN104718207A (zh) | 2015-06-17 |
| BR112014033056A2 (pt) | 2017-06-27 |
| JP6190881B2 (ja) | 2017-08-30 |
| IN2014MN02554A (xx) | 2015-07-24 |
| WO2014005217A1 (en) | 2014-01-09 |
| CA2878332C (en) | 2019-04-30 |
| CA2878332A1 (en) | 2014-01-09 |
| US20160375027A1 (en) | 2016-12-29 |
| KR20150041784A (ko) | 2015-04-17 |
| JP2015521987A (ja) | 2015-08-03 |
| US20150344478A1 (en) | 2015-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1215577A1 (zh) | 蛋白激酶抑制劑 | |
| HK1217198A1 (zh) | 蛋白激酶抑制劑 | |
| HK1200451A1 (zh) | 蛋白激酶抑制劑 | |
| HK1210775A1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
| HK1208442A1 (en) | Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors mknk | |
| EP2694517A4 (en) | PROTEIN KINASE INHIBITORS | |
| HK1222647A1 (zh) | 激酶抑制劑 | |
| EP2710007A4 (en) | Kinase Inhibitors | |
| HK1205507A1 (en) | Protein kinase inhibitors | |
| ZA201306855B (en) | Protein kinase inhibitors | |
| HK1209726A1 (en) | Protein kinase inhibitors | |
| EP2833889A4 (en) | PROTEIN KINASE C HEMMER AND USES THEREOF | |
| HK1218119A1 (zh) | 蛋白激酶抑制劑 | |
| HK1208460A1 (en) | Protein kinase inhibitors | |
| EP2702064A4 (en) | Kinase Inhibitors | |
| HK1199873A1 (en) | Kinase inhibitors | |
| SG11201500973WA (en) | Amino-quinolines as kinase inhibitors | |
| IL230504A0 (en) | Selective protein kinase inhibitors | |
| EP2879679A4 (en) | ANTIBACTERIAL PROTEIN KINASE INHIBITORS | |
| HK1210036A1 (en) | Aminoisoquinoline derivatives as protein kinase inhibitors |